Alkaline Phosphatase Blocking Solution (Levamisole Method) - BioReagent,Suitable for microbiology,for microscopy

Cat. No.: A1508984

GRAU & PUREZA BioReagent, Suitable for microbiology, for Microscopy

Synonyms

Alkaline Phosphatase Blocking Solution

Storage

Room temperature

Shipped In

Normal

Application

Cell Staining, IHC

Visão geral

Product Introduction

Alkaline phosphatase can be used in ELISA assays, and its reaction product is a soluble colored substance, which is commonly used for quantitative determination with a spectrophotometer. Although paraffin embedding can inactivate most alkaline phosphatase, the residual enzyme can still interfere with the labeling effect.

Alkaline Phosphatase Blocking Solution (Levamisole Method) consists of levamisole, preservatives and other components, and can effectively block all alkaline phosphatase isoforms except the intestinal one. This reagent is for research use only and not intended for clinical diagnosis or any other applications.

Operating Procedures (For Reference Only)

1. Mount the sections on glass slides and rinse gently with PBS.

2. Blot or air-dry the slides, then incubate them in Alkaline Phosphatase Blocking Solution (Levamisole Method) for 10-20 minutes.

3. Proceed to blot or air-dry the slides directly without rinsing.

4. Incubate the slides with unlabeled primary antibody.

Precautions

1. For your safety and health, wear a lab coat and disposable gloves during operation.

2. Use the reagent as soon as possible after opening to avoid compromising the results of subsequent experiments.

Especificações

Sinónimos

Alkaline Phosphatase Blocking Solution

Especificações e pureza

BioReagent,Suitable for microbiology,for microscopy

Estabilidade e armazenamento

Store at room temperature long term (12 months).

Condições de armazenamento de armazenamento

Room temperature

Enviado em

Normal

Grau

BioReagent, para microscopia, Suitable for microbiology

Product Line

Produtos biológicos

Application Protocols

Item‑specific protocols are not provided; refer to the CoA/Spec Sheet. The following are general workflows (literature) for levamisole‑based AP blocking:

IHC/ICC (chromogenic AP detection):

• Rehydrate sections and perform antigen retrieval as needed.
• Block non‑specific binding (e.g., serum/protein block) per your method.
• Incubate with Alkaline Phosphatase Blocking Solution (Levamisole Method) for 10–30 minutes at room temperature with gentle agitation.
• Wash 2–3 × 5 minutes in working buffer (PBS/TBS).
• Proceed with AP‑conjugated primary/secondary detection and substrate development (e.g., BCIP/NBT or Fast Red).

ISH (AP‑based detection):

• After post‑hybridization washes and blocking, treat with AP blocking solution as above.
• Rinse thoroughly; then add AP‑conjugated probe/antibody and develop signal.

Western/Dot blot:

• After transfer and membrane blocking, incubate membrane in AP blocking solution for 10–20 minutes at room temperature.
• Wash and proceed with AP‑conjugated detection reagents.

Controls and optimization:

• Include a no‑blocking control to assess background.
• If residual background persists, confirm tissue isoform profile and consider alternative detection enzymes. Adjust incubation time empirically.

Biological Roles

Context for use (general/literature): Endogenous alkaline phosphatases (APs) are metalloenzymes that hydrolyze phosphate esters, contributing to dephosphorylation in diverse tissues. Major human isoenzyme families include tissue‑nonspecific AP (TNAP; expressed in liver, bone, kidney), intestinal AP (IAP), and placental/germ cell AP.

• AP function: Dephosphorylation of nucleotides, proteins, and other phosphomonoesters; roles in mineralization (TNAP), gut barrier function and LPS detoxification (IAP), and placental physiology (PLAP).
• Levamisole inhibition: Levamisole selectively inhibits TNAP and many non‑intestinal AP isoforms through interaction with the active site (literature). Intestinal and placental isoforms are characteristically levamisole‑insensitive, which has diagnostic utility in isoenzyme typing.
• Relevance to assays: Blocking endogenous AP prevents enzyme‑mediated background during chromogenic/chemiluminescent detection that uses AP conjugates, improving specificity of antigen or nucleic acid localization.

Note: These are general biological roles of AP isoenzymes and the levamisole inhibitor. They describe the rationale for using an AP blocking solution and are not claims about the composition of this specific SKU.

Buffer Applications

This product is not a general‑purpose buffer but a specialized blocking reagent for endogenous alkaline phosphatase. Buffer formulation details (buffer species, pH, ionic strength) are not specified for this item; refer to the CoA/Spec Sheet.

Practical guidance (general/literature):

• Use the blocking solution within the same buffer system as your detection workflow (e.g., PBS or TBS) to avoid osmotic or pH shocks to sections.
• Follow with wash steps in the working buffer prior to introduction of AP‑conjugated reagents and substrates.

For applications requiring defined buffering capacity or pH control, select an appropriate analytical buffer product instead.

Green Alternatives

Greener‑by‑design considerations focus on reducing hazardous components and waste in AP‑based detection workflows rather than substituting the blocking solution itself.

Options and trade‑offs (general/literature):

• Use minimal effective volume and time: Reduces reagent consumption and rinse volumes without compromising blocking efficiency.
• Preservative profile: If the workflow allows, select preservative‑free or low‑hazard preservative formulations to reduce aquatic toxicity; composition for this item is not specified—consult CoA/SDS.
• Alternative detection systems: Horseradish peroxidase (HRP) systems avoid the need for AP blocking but introduce H2O2 quenching steps and may use aromatic amine substrates. Polymer‑based fluorescence detection eliminates chromogens but may require organic mounting media.
• Substrate selection: Water‑based, low‑hazard chromogens (e.g., stabilized BCIP/NBT kits) can reduce solvent use compared with certain legacy substrates.

Small comparison (general):

• AP + levamisole blocking: High sensitivity, stable chromogens; requires endogenous AP suppression; good for multi‑day staining.
• HRP + H2O2 quenching: Widely available substrates; sensitive to heme/peroxidase background; typically faster development; no AP blocking needed.

Overall, choose the detection path that minimizes hazardous inputs for your assay while delivering the required sensitivity and resolution.

Pharmaceutical Uses

Not applicable. This product is intended for research and microscopy workflows and is not formulated, tested, or certified for pharmaceutical manufacturing or as a medicinal product.

General note (literature): While alkaline phosphatase and levamisole have historical relevance in clinical diagnostics and pharmacology, this SKU is for laboratory research use only, as stated by the manufacturer. Do not use for diagnostic, therapeutic, or in vivo applications.

Physical Properties

As a formulated aqueous solution, conventional single‑compound physical constants are not applicable. Item‑specific specifications have not been provided.

• Appearance: Not specified for this item; refer to CoA/Spec Sheet.
• pH: Not specified for this item; refer to CoA/Spec Sheet.
• Density, refractive index, osmolality: Not specified for this item; refer to CoA/Spec Sheet.
• Solubility: Ready-to-use solution (literature expectation: water-based and miscible with water; item-specific details not specified).
• Boiling point / melting point / vapor pressure: Not applicable/relevant for standard laboratory use of aqueous solutions; not specified for this item.

Notes (general/literature): AP blocking solutions are typically buffered in the neutral–alkaline range to match conditions used for AP‑conjugate activity development, but exact buffer system and pH vary by manufacturer and should be confirmed on the CoA/Spec Sheet for this SKU.

Quality and Grades

• Grade/Purity (item-specific): BioReagent; Suitable for microbiology; for Microscopy.
• Interpretation:
  • BioReagent: Suitable for biological research applications, emphasizing low levels of contaminants that could interfere with enzyme activity or staining performance.
  • Suitable for microbiology: Manufactured and packaged to minimize microbial contamination and bioburden, supporting reproducible results in workflows where sterility or low background flora is important.
  • For Microscopy: Optimized for histological and cytological procedures, emphasizing clarity, low particulate content, and consistent staining/background characteristics.
• Stabilizers/Preservatives: Not specified for this item; refer to CoA/Spec Sheet. If present, preservatives (e.g., azide) may influence compatibility with peroxidase‑based methods or certain downstream applications—verify before use.
• Release criteria: Item‑specific specifications for pH, inhibitor content, and performance testing are not provided here; consult the CoA/Spec Sheet for target values and QC results.

Practical impact: This grade is intended to deliver reliable suppression of endogenous alkaline phosphatase activity in tissue sections and blots, minimizing non‑specific chromogenic or chemiluminescent background when AP‑conjugated detection systems are used.

Reaction and Applications

This solution is used to inhibit endogenous alkaline phosphatase (AP) activity in biological samples prior to AP-based detection, thereby reducing background signal.

Key applications (general/literature):

• Immunohistochemistry (IHC) and immunocytochemistry (ICC): Incubation of sections/cells with levamisole blocking solution suppresses endogenous AP in many tissues, improving signal-to-noise for AP‑conjugated antibodies or streptavidin‑AP systems.
• In situ hybridization (ISH): Minimizes background from tissue AP when chromogenic AP substrates (e.g., BCIP/NBT) are used for probe detection.
• Western and dot blots: Pre‑treat membranes or incubate samples to reduce non‑specific AP activity that can contribute to background during colorimetric or chemiluminescent AP development.

Mechanistic note (literature): Levamisole is a selective inhibitor of tissue‑nonspecific AP (TNAP; liver/bone/kidney isoforms). Intestinal and placental AP isoenzymes are typically resistant to levamisole; if those isoforms are predominant, residual background may persist and alternative strategies may be required.

Practical tips (general):

• Apply after blocking non-specific protein binding and prior to the AP‑conjugated reagent.
• Maintain consistent incubation time and temperature for reproducibility; avoid extended exposures that may affect tissue antigenicity.
• Verify compatibility with your substrate system; levamisole does not inhibit the AP conjugate itself at typical blocking concentrations but confirm empirically.

Reaction Conditions

As a blocking step in bioassays rather than a chemical reaction, conditions are operational parameters. Item‑specific instructions are not provided; consult the CoA/Spec Sheet. The following guidance is general (literature):

• Sample types: FFPE or cryosections, cytospins, cultured cells, nitrocellulose/PVDF membranes.
• Incubation: 10–30 minutes at room temperature with gentle agitation is commonly effective for levamisole‑based AP blocking. Adjust time based on tissue AP levels and background in pilot tests.
• Concentration: Commercial levamisole blocking solutions are typically used as supplied. For made‑in‑lab buffers, 1–5 mM levamisole is a commonly cited range; this item’s concentration is not specified.
• Sequence: Perform after rehydration and protein blocking, before applying AP‑conjugated primary/secondary reagents. Follow with thorough buffer washes (e.g., 2–3 × 5 minutes).
• Compatibility: Optimized for AP‑based detection (e.g., BCIP/NBT, Fast Red). It does not substitute for endogenous peroxidase quenching required for HRP systems.
• Temperature: Room temperature is standard; cooler temperatures may require longer incubations.

Always validate on representative samples, as AP expression and isoform composition vary among tissues, potentially influencing blocking efficacy.

Safety and Handling

• GHS classification, signal word, pictograms, H‑statements: Not specified for this item; consult the product SDS for authoritative safety information.
• Likely hazards (general/literature): Solutions containing levamisole or common preservatives (e.g., sodium azide) may cause skin/eye irritation; avoid ingestion and inhalation. Composition for this item is not specified—use standard caution.
• PPE: Laboratory coat, safety glasses, and appropriate chemical‑resistant gloves. Use in a well‑ventilated area or biological safety cabinet when working with tissue sections.
• First aid overview (general): In case of skin/eye contact, rinse with water for several minutes; remove contaminated clothing. If inhaled, move to fresh air. If ingested, rinse mouth. Seek medical attention as needed. Always follow the SDS.
• Handling: Avoid microbial contamination of the container. Do not mix with developer/substrate solutions in the same vessel. Close cap promptly to minimize evaporation and contamination.
• Incompatibilities (general/literature): Avoid strong oxidizers or acids/bases that could degrade buffer components or levamisole. Do not add metal ions or detergents unless validated for the assay, as they can affect AP activity and blocking efficacy.
• Waste: Collect aqueous laboratory chemical waste according to institutional and local regulations. Do not dispose to drain unless permitted and free of hazardous preservatives.

Defer to the SDS for definitive hazard and response instructions for this SKU.

Solvent Selection

Not a solvent—this is a ready-to-use aqueous blocking solution. Solvent selection is generally not applicable.

• Matrix compatibility (general/literature): Designed for use with hydrated biological samples (FFPE or cryosections) and membrane blots. Compatible with standard aqueous buffers used in immunohistochemistry (IHC), in situ hybridization (ISH), and Western blot detection workflows.
• Mixing/dilution: Item provides no instructions on dilution; use as supplied unless the CoA/Spec Sheet specifies otherwise. If dilutions are required, use the same buffer system as your detection workflow to maintain ionic strength and pH.
• Order of operations: Apply after sample rehydration and blocking of non‑specific binding sites, and before addition of alkaline phosphatase–conjugated probes/secondary reagents.
• Alternatives: If solvent selection is needed for washes, typical choices include PBS, TBS, or Tris buffers (literature). Verify the buffer used for chromogenic substrates (e.g., BCIP/NBT) is compatible with the AP system you employ.

Storage and Reconstitution

• Storage conditions (item-specific): Room temperature.
• Shipped in (item-specific): Normal.
• Format: Not specified for this item; refer to CoA/Spec Sheet (ready‑to‑use vs. concentrate vs. powder not indicated).
• Reconstitution/Dilution: Not specified for this item; follow CoA/Spec Sheet if concentration or dilution instructions are provided. If supplied as a concentrate, bring to working strength with the recommended buffer.
• Stability/Opened shelf life: Not specified for this item; consult CoA/Spec Sheet and SDS. Avoid contamination; dispense using clean serological or positive‑displacement pipettes.
• Freeze–thaw: Generally not required or recommended for aqueous blocking solutions unless specified by the manufacturer. Protect from microbial contamination and extreme temperatures.
• Handling: Mix gently before use to ensure homogeneity. If particulates or precipitation are observed, do not use until clarified by the manufacturer’s guidance.

Research Use Note (item-specific): For research use only.

Structure and Identity

This product is a formulated laboratory solution intended to block endogenous alkaline phosphatase (AP) activity using the levamisole method. It is a mixture (not a single defined compound), therefore small‑molecule identifiers are not applicable to the product as sold.

• Item type: ready-to-use AP blocking solution (levamisole method)
• Composition: Not specified for this item; refer to CoA/Spec Sheet.
• Molecular formula / Molecular weight (of product): Not applicable for a mixture; not specified for this item.
• SMILES / InChI / InChIKey: Not applicable for a mixture.
• Structural features (general/literature): levamisole is a heterocycle (imidazothiazole) used as a selective inhibitor of tissue‑nonspecific and liver/bone/kidney AP isoenzymes; intestinal and placental AP are typically levamisole‑insensitive (literature).
• 2D description (general/literature): In practice, the solution is an aqueous buffer containing levamisole salt at an inhibitor concentration suitable for blocking endogenous AP activity prior to AP‑based detection in histochemistry or blotting; exact species and concentration are not specified for this item.

Synthetic Utility

Not applicable. This is a biological blocking solution used in histology/blotting workflows rather than a reagent for chemical synthesis or transformation.

For chemical synthesis applications involving alkaline phosphatase or phosphatase inhibitors, consult enzyme substrates/inhibitors designed for biochemical assays, not blocking solutions intended for microscopy.

Target Specificity

This SKU is not an antibody or probe; there is no antigen/epitope specificity. Instead, specificity relates to enzyme isoforms inhibited during the blocking step.

Isoenzyme sensitivity to levamisole (literature, general):

| Alkaline phosphatase isoform | Levamisole sensitivity | | --- | --- | | Tissue‑nonspecific AP (TNAP; liver/bone/kidney) | Sensitive (inhibited) | | Non‑intestinal tissue AP (various) | Generally sensitive | | Intestinal AP (IAP) | Resistant (not inhibited) | | Placental AP (PLAP) and germ cell AP | Resistant (not inhibited) |

Implication: The blocking solution effectively reduces background when endogenous AP activity derives from levamisole‑sensitive isoforms. If tissues express primarily levamisole‑resistant AP (e.g., intestinal mucosa, placenta), alternative strategies (different detection enzyme, modified substrates, or additional inhibitors) may be required.

Perguntas frequentes

What does Suitable for microbiology mean?

Suitable for microbiology indicates that the product has been processed and tested for extraction workflows and microbiology. Specifications may include endotoxin limits, microbial controls, sterility, low DNase/RNase/protease activity, and verified biological activity where relevant.

What does BioReagent mean?

BioReagent indicates that the product has been processed and tested for biological and biochemical applications. Specifications may include endotoxin limits, microbial controls, sterility, low DNase/RNase/protease activity, and verified biological activity where relevant.

How is this product shipped?

This product ships under standard ambient conditions. No temperature-controlled packaging is required.

What documentation is provided?

Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.